Journal
JOURNAL OF SURGICAL ONCOLOGY
Volume 123, Issue 1, Pages 71-79Publisher
WILEY
DOI: 10.1002/jso.26236
Keywords
breast neoplasms; de-escalation; neoadjuvant therapy; pathologic complete response; survival
Ask authors/readers for more resources
This study demonstrates that achieving a pathologic complete response is beneficial for breast conservative surgery and sentinel lymph node biopsy. In selected subgroups, avoiding any axillary surgery after neoadjuvant treatment may be feasible. In cN+ patients, any pathologic complete response is associated with improved survival.
Introduction Breast conservative surgery (BCS) and sentinel lymph node biopsy (SLNB) after neoadjuvant treatment (NAT) is safe and effective for selected patients. This aim of this study is to evaluate the impact of anatomic site of response on outcomes and to assess the real population who may benefit from nonsurgical approaches after NAT. Material and Methods From a prospectively maintained database, patients with T1-4 N0-2 breast cancer undergoing NAT were identified. Clinicopathological and survival rates were compared in relation to response and anatomic site of response. Results Six hundred and forty-six patients were included in the study. Pathologic complete response (pCR) was an independent factor for BCS and SLN. HER2 positive and TN tumors with cN0 achieving a breast pCR remain ypN0 (p = .002). Residual axillary disease was associated with breast residual tumor (p = .05) and subtype (p = .001). With a median follow up of 35.25 months, patients with any pCR had improved survival when compared with partial response, but not significant differences between pCR, axillary pCR, or breast pCR. Conclusion Achieving a pCR increases BCS and SLN. In selected subgroups, sparing any axillary surgery after NAT maybe feasible. In cN+ patients, any pCR was associated with survival, but not the anatomic site of response.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available